Advocacy intelligence hub — real-time data for patient organizations
Treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Firdapse
(AMIFAMPRIDINE PHOSPHATE)Orphan drugCatalyst Pharmaceuticals, Inc.
12.1 Mechanism of Action The mechanism by which amifampridine exerts its therapeutic effect in LEMS patients has not been fully elucidated. Amifamprid...
Andrew G Engel, MD
Mayo Clinic
Laurent Servais, MD
Centre Hospitalier Universitaire de Liege
Leona Holmberg
Fred Hutch/University of Washington Cancer Consortium
📍 SEATTLE, WA
Christopher Grunseich, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
📍 Bethesda, Maryland
Perry Shieh, MD, PhD, MD
University of California, Los Angeles
📍 LOS ANGELES, CA
Kathy L Aleš, MD
Jacobus Pharmaceutical